Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis (Q36573444)
Jump to navigation
Jump to search
scientific article published on 8 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis |
scientific article published on 8 December 2015 |
Statements
1 reference
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis (English)
1 reference
Stefan Braune
1 reference
M Lang
1 reference
A Bergmann
1 reference
NeuroTransData Study Group
1 reference
1 reference
8 December 2015
1 reference
Identifiers
1 reference